NCT07082270 2026-04-15Selvigaltin With Standard of Care Treatment for the Treatment of Relapsed/Refractory Multiple MyelomaRoswell Park Cancer InstitutePhase 1 Withdrawn
NCT05521087 2025-06-22A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute LeukemiasJanssen Research & Development, LLCPhase 1 Withdrawn